Matthew Lanza

Matthew Lanza is an Assistant Professor in the Department of Comparative Medicine, focusing on veterinary pathology and comparative medicine. His research emphasizes rodent models in cancer therapy evaluation, immunotherapy efficacy (e.g., CAR-T cells), and immune responses to infectious agents. He has contributed to studies on wound healing biomaterials and histopathological scoring systems.

Research Interests: Dr. Lanza’s work spans cancer immunotherapy, infectious disease pathogenesis, and translational medicine. He collaborates across disciplines to assess therapeutic toxicity and efficacy in preclinical models. Recent studies include mechanisms of antimicrobial defense in intestinal fibroblasts and the role of red blood cells in sepsis host responses.

Awards:

• Dean's Award for Excellence in Teaching (2023)
• Dean's Award for Excellence in Teaching (2024)

Key Contributions: His publications address critical areas such as biomaterial biocompatibility, electronic cigarette lung toxicity, and Yersinia infection dynamics. He maintains active collaborations in veterinary pathology and translational biomedical research.